Financial Highlights - Netwealth's total Funds Under Administration (FUA) reached $118.5 billion as of August 18, 2025[19, 125, 129] - FUA net flows increased by 40.4% from FY24 to $15.8 billion in FY25[19, 77] - Total income grew by 27.1% to $324.4 million in FY25[19, 77] - EBITDA increased by 31.1% to $163.5 million, with an EBITDA margin of 50.4%, a 3.2% increase[19] - Net Profit After Tax (NPAT) increased by 39.8% to $116.5 million[19, 77] Business Growth and Diversification - Managed Account FUM grew by 33.5% and Managed Funds FUM grew by 21.9%[30] - Domestic trade volume increased by 28.5%, while international trade volume increased significantly by 121.9%[30] - The number of financial intermediaries increased by 5.6% to 3,971, leading to a 13.3% increase in the number of accounts to 162,234[32] Revenue and Customer Segments - Transaction fee income increased by 47.7%, representing 14.0% of Platform Revenue[26, 84] - Management fee income increased by 31.1%, representing 6.1% of Platform Revenue[23, 84] - High Net Worth (HNW) FUA increased from 22.4% to 23.4%, and Ultra High Net Worth (UHNW) & Family Office FUA increased from 10.2% to 11.6%[52]

AMAERO LTD (ASX: 3DA | OTC: AMROF) A leading U.S. domestic producer of high -value refractory and titanium alloy spherical powders & manufacturer of near-net - shape parts for mission -critical components across defense, space, aviation, medical and industrials Investor Presentation August 2025 For personal use only Important Notice and Disclaimer This investor presentation (Presentation) is dated 21 August 2025 and has been prepared by Amaero Ltd (ACN 633 541 634) (Amaero) in relation to a non-underwritten ...

Financial Performance - SQM's Q2 2025 revenue reached US$1,043 million[7], gross profit was US$254 million[7], and net income totaled US$308 million[7] - Earnings per share stood at US$0.31[7] - Lithium LTM revenue reached $1,977 million[12], with a gross profit of $410 million[12] - Iodine LTM revenue reached US$985 million[23], with a gross profit of US$523 million[23] - Specialty Plant Nutrition LTM revenue reached US$946 million[33], with a gross profit of US$146 million[33] - Potassium LTM revenue reached US$217 million[40], with a gross profit of US$28 million[40] - Industrial Chemicals LTM revenue reached US$74 million[46], with a gross profit of US$28 million[46] Market Dynamics and Outlook - The global lithium market is expected to grow by approximately 17% in 2025[18] - SQM anticipates a sales volume growth of around 10% in the Lithium Chile division compared to 2024[18] - The company expects to sell approximately 20,000 tons of LCE for the International Lithium Division in 2025[18] - Global iodine demand growth is updated to less than 1% in 2025 compared to 2024[29] - SQM expects a market growth rate of around 4-5% in 2025 for Specialty Plant Nutrition[36] - Potassium sales volume for 2025 is expected to decline by 50% compared to 2024[42] Strategic Investments - Total Capex for 2025 is estimated at US$750 million, including maintenance[21] - Iodine and Nitrates total capex for 2025 is approximately US$350 million, including maintenance[31] Market Share - SQM holds approximately 17% of the global lithium chemical market[12] - SQM holds approximately 37% of the global iodine market[28] - SQM holds approximately 41% of the global KNO3 market[38] - SQM holds less than 1% of the global potash market[43] - SQM holds approximately 32% of the global industrial potassium nitrate market[49]

Financial Performance - GAAP Net Income was $102 million or $027 per share[11] - NAV-Based Total Return was 197% annualized[11] - Net Investment Income was $65 million or $017 per share[11] - Adjusted Net Investment Income was $66 million or $018 per share[11] - Net Asset Value was $2297 million or $612 per share as of June 30 2025[11] Investment Portfolio - The CLO portfolio grew by 27% to $3169 million as of June 30 2025 from $2499 million as of March 31 2025[11, 18] - CLO debt investments totaled $1489 million with 79% in the U S and 21% in Europe[11] - CLO equity investments totaled $1680 million with 92% in the U S and 8% in Europe[11] - The company purchased $906 million of CLO investments and sold $159 million[11] - The weighted average GAAP yield for the quarter based on amortized cost was 156% on the total CLO portfolio[11] Distributions - The company received $159 million in recurring cash distributions from the investment portfolio or $042 per share[11] - The distribution rate was 172% based on the August 18 2025 closing stock price of $559 and a monthly distribution of $008 per common share declared on August 7 2025[11]

Q2 2025 Financial Performance - Lowe's reported positive comparable sales growth of +1.1%[1] and a gross margin of 33.8%[1], which is an increase of +34 basis points compared to the previous year[1] - Adjusted operating margin reached 14.7%[2], up +23 basis points year-over-year[2], with diluted EPS at $4.27[2], a +2.4% increase[2], and adjusted diluted EPS at $4.33[2], a +5.6% increase[2] - The company returned $645 million to shareholders through dividends[2] Sales Trends - Comparable transactions decreased by -1.0%[3], while the comparable average ticket increased by +0.3% to $104.60[3] - Online sales growth experienced a decline of -6.4%[3] - Monthly comparable sales performance varied, with May at -1.8%[3], June at +2.9%[3], and July at +7.5%[3] - Comparable sales by ticket size showed growth in the >$500 range at +3.6%[3], a decrease in the $100-$500 range at -1.4%[3], and a decrease in the <$100 range at -0.1%[3] - Positive comparable sales were achieved in 9 out of 14 product categories[5], including Building Materials, Lawn & Garden, and Appliances[5] Strategic Initiatives - Lowe's closed on the acquisition of Artisan Design Group (ADG)[6] - Pro penetration has increased from approximately 19% in 2019 to approximately 30% in 2025[23] - Lowe's announced the acquisition of Foundation Building Materials (FBM) on August 20, 2025[12] Foundation Building Materials (FBM) Acquisition - FBM has approximately $6.5 billion in pro forma 2024 revenue and $635 million in adjusted EBITDA[27] - The purchase price of $8.8 billion reflects a multiple of 13.4x adjusted EBITDA[50]

Financial Performance - Second quarter revenues reached $84 million with a TCE (Time Charter Equivalent) rate of $72,000 per day[7] - Net income was $17.7 million, and adjusted net income was $24.8 million[7] - Earnings Per Share (EPS) was $0.33, and adjusted EPS was $0.46[7] Guidance and Outlook - The company reconfirmed its 2025 revenue guidance of approximately $340-360 million, with a TCE rate of $72,000-77,000 per day[7] - Adjusted EBITDA for 2025 is reconfirmed at around $250-270 million[7] Balance Sheet and Refinancing - Refinancing of Flex Courageous was completed, yielding net proceeds of approximately $43 million[27, 31] - Three refinancings are expected to generate around $132 million in net proceeds and lower the average pro forma cost of debt to approximately 5.6%[31] - The company's interest rate swap portfolio stood at $850 million (notional) with a weighted average rate of 2.33%[34] Dividends and Share Buy-Back - A dividend of $0.75 per share was declared for the second quarter[7] - The dividend per share for the last twelve months is $3.00[7] - A share buy-back program of up to $15 million has been launched[7, 39] Operational Updates - Two out of four planned drydockings have been completed ahead of schedule[8, 13] - The estimated average cost of all four drydockings is approximately $5.7 million per vessel[13] Market Trends - Global LNG exports YTD-2025 amounted to 244.7 MT, representing a 2% increase[41] - US LNG exports have surged, accompanied by approximately 24% growth in European LNG imports[40, 41]

Financial Performance - Total contract revenues increased by 14.5% from $1.2031 billion in Q2 2025 to $1.3779 billion in Q2 2026[5] - Organic revenue growth was 3.4%[5] - Adjusted EBITDA increased by 29.8% from $158.3 million in Q2 2025 to $205.5 million in Q2 2026[5] - Adjusted EBITDA margin improved by 175 bps from 13.2% in Q2 2025 to 14.9% in Q2 2026[5] - Adjusted diluted EPS increased by 35.4% from $2.46 in Q2 2025 to $3.33 in Q2 2026[5] Backlog and Outlook - Total backlog increased by 16.9% year-over-year[24] - Next 12 months backlog increased by 20.2% year-over-year[24] - The company reaffirms fiscal year 2026 revenue outlook range of $5.290 billion to $5.425 billion, representing a growth of 12.5% to 15.4% over the prior year[31] Debt and Liquidity - Total notional amount of debt was $1.035 billion in Q2 2026[25] - Notional net debt was $1.0065 billion in Q2 2026[25] - Liquidity was $545.9 million in Q2 2026[25]

Market Position and Strategy - Public homebuilders have increased their market share from 27% in 2012 to approximately 53% in 2024[15] - The company focuses on capital efficiency in land acquisition through optioned land, land banking, joint ventures, rolling takedowns, and seller financing[45] - The company is strategically focused on driving shareholder returns through land acquisition, improved operations, and buybacks & dividends[39] Financial Performance - The company's diluted earnings per share (EPS) has grown at a compound annual growth rate (CAGR) of 28%, reaching $1501 in FY 2024[54] - The company has repurchased approximately 52% of its shares since 2016, totaling 91 million shares at an average price of $50, and has paid approximately $644 million in dividends[63] - The company's revenue from home sales increased from $6937357000 in FY 2020 to $10563332000 in FY 2024[66] - The company's return on beginning equity was 231% in FY 2024[66] Industry Trends - The new home premium has compressed from a historical 17% to 3% in 2025, making the value proposition of a new home compelling compared to a used home[23] - The median age of owner-occupied U S homes is over 40 years, compared to 32 years in 2005[27] - Housing starts have not kept pace with household growth, indicating an undersupplied market[20] Land and Operations - The company operates in 24 states and over 60 markets[33] - The company's total addressable market (TAM) consists of approximately 575000 housing transactions with buyers having income greater than $200K[73]

COVID-19 Landscape and Strategy - COVID-19 is the leading cause of hospitalizations and death from respiratory viruses in the U S, with 460,000 hospitalizations and 45,200 deaths between October 1, 2023, and June 15, 2024[7] - The company believes COVID-19 vaccines do not provide sufficient protection, with vaccine effectiveness against hospitalization for immunocompromised adults at a maximum of approximately 36% within 7-59 days of the 2023-2024 vaccine dose[19] - Monoclonal antibodies have demonstrated a significant reduction in the risk of symptomatic COVID-19, with pemivibart showing an 84-94% reduction in risk in ordinary Americans[22] - The company aims to provide Americans with a choice for COVID-19 protection through VYD2311, a monoclonal antibody with high efficacy and long duration of protection, contrasting with the reactogenic and modestly effective COVID-19 vaccines[48, 49] Pipeline and Development - Pemgarda has received emergency use authorization (EUA) from the U S FDA in March 2024 for pre-exposure prophylaxis of COVID-19 in certain immunocompromised persons[29] - VYD2311 is designed to be a high potency, long half-life monoclonal antibody for COVID-19, with an observed IM half-life of 76 days in the first-in-human trial[39, 40] - The company is planning a Phase 2/3 clinical trial for VYD2311 for the prevention of COVID-19, supported by a single, randomized, double-blind, placebo-controlled trial[29] - The company is in the discovery phase for RSV prevention and early discovery for measles and influenza prevention[29] Financials - Q2 2025 Pemgarda net product revenue was $11 8 million[66] - The company ended Q2 2025 with approximately $34 9 million in cash and cash equivalents[66]

Q2 2025 Earnings Call August 20, 2025 G1_Dallas T1 Energy _ Q2 2025 Earnings Call Pictured: Production lines at G1_Dallas T1 Energy _ Q2 2025 Earnings Call Participants and Agenda Prepared Remarks Daniel Barcelo Chairman of the Board and Chief Executive Officer Jaime Gualy Chief Operating Officer Andy Munro Chief Legal & Policy Officer ▪ Corning supply agreement ▪ Policy overview ▪ T1's OBBB compliance road map Evan Calio Chief Financial Officer Q&A Jeff Spittel EVP, Investor Relations and Corporate Develop ...